Michele Baccarani, MD
Head of the Institute of Hematology and Medical Oncology "L. and A. Seràgnoli",
S. Orsola at the University Hospital, Bologna, ITALY.
Matías Chacón, MD
Medical Oncologist at the Instituto Médico Alexander Fleming in Buenos Aires; ARGENTINA
Jorge E. Cortes, MD
Professor of Medicine, Chief/CML Section, Deputy Chair, Department of Leukemia,
MD Anderson Cancer Center in Houston, Texas, USA.
George D. Demetri, MD
Director of the Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute
Associate Professor of Medicine, Harvard Medical School, USA.
Brian J. Druker, MD
Investigator, Howard Hughes Medical Institute, JELD-WEN Chair of Leukemia Research,
John M. Goldman, MD
Chairman, Department of Hematology, Imperial College Faculty of Medicine General
Secretary of the World Marrow Donor Association, UK.
Francois Guilhot, MD
Head of the Department of Oncology, Hematology and Cell Therapy at The University
Hospital of Poitier. President of the Chronic Myelogenous Leukemia French Group,
Andreas Hochhaus, MD
Klinikum Mannheim der University Heidelberg in Mannheim, GERMANY.
Timothy Hughes, MD
Hanson Institute, SA Pathology Adelaide, SOUTH AUSTRALIA.
Michael J. Mauro, MD
Professor of Medicine, Division of Hematology and Medical Oncology at Oregon Health
and Science University (OHSU) in Portland, Oregon, USA.
Jerald Radich, MD
Clinical Research Division, Member with Fred Hutchinson Cancer Research Center and
Professor of Medicine at University of Washington, USA.
Peter Reichardt, MD
Head of the Department of Interdisciplinary Oncology Director of the Sarcoma Center
Berlin-Brandenburg Director of the Cancer Center Berlin-Buch at HELIOS Klinikum
Berlin-Buch in Berlin; GERMANY.
Moshe Talpaz, MD
Assoc. Director for Translational Research, The University of Michigan Health Systems,
Ann Arbor, Michigan, USA.
Jonathan Trent, MD
Co-Director, Musculosketal Center Director, Sarcoma Medical Research Program Professor
of Medicine at Sylvester Cancer Center in Miami, Florida; USA
Back to About Us